Noha Elemam | Immuno-oncology | Women Researcher Award

Women Researcher Award

Noha Elemam
University of Sharjah, United Arab Emirates
Noha Elemam
Affiliation University of Sharjah
Country United Arab Emirates
Scopus ID 56442766900
Documents 97
Citations 14513
h-index 28
Subject Area Immuno-oncology
Event International Young Scientists Award
ORCID 0000-0002-3586-6731

Noha Elemam is a researcher affiliated with the University of Sharjah, United Arab Emirates, recognized for scholarly contributions in the field of Immuno-oncology. Her research profile demonstrates extensive publication activity, high citation visibility, and measurable scientific impact in cancer immunology and translational biomedical research.[1] The researcher’s work contributes to scientific understanding of immune responses in oncology and the development of therapeutic strategies within modern biomedical sciences.[2]

Abstract

This article presents an academic overview of Noha Elemam and her scholarly contributions in Immuno-oncology. The profile summarizes research productivity, citation performance, publication visibility, and scientific engagement in biomedical and cancer immunology research.[1] The documented research indicators demonstrate substantial academic influence within internationally indexed scientific literature and translational oncology studies.[3]

Keywords

  • Women Researcher Award
  • Immuno-oncology
  • Cancer Immunology
  • Biomedical Research
  • Scientific Publications
  • Translational Medicine
  • Academic Excellence
  • International Young Scientists Award

Introduction

Immuno-oncology is a rapidly developing biomedical discipline focused on understanding the interactions between the immune system and cancer progression. Scientific advances in this area contribute to immunotherapeutic strategies, cancer diagnostics, targeted therapies, and translational clinical applications.[2]

Noha Elemam has contributed to scientific investigations within oncology and immunological sciences through peer-reviewed research publications and internationally indexed scholarly dissemination. Her academic profile reflects significant visibility and measurable impact within biomedical literature databases.[1]

Research Profile

According to indexed scholarly databases, Noha Elemam has authored 97 scientific documents with more than 14,500 citations and an h-index of 28. These metrics demonstrate substantial research dissemination, citation visibility, and influence within biomedical sciences and Immuno-oncology research.[1]

The researcher’s affiliation with the University of Sharjah supports interdisciplinary biomedical research and collaboration in oncology, immunology, and translational medicine. Academic profiles available through ORCID, Google Scholar, and Scopus further enhance international research accessibility.[4]

  • Affiliation: University of Sharjah
  • Country: United Arab Emirates
  • Scopus Indexed Documents: 97
  • Citation Count: 14513
  • h-index: 28
  • Research Area: Immuno-oncology

Research Contributions

Research contributions associated with Noha Elemam involve cancer immunology, immune regulation, translational oncology, and therapeutic mechanisms related to tumor progression and immune system interactions.[2] Such investigations contribute to scientific understanding of immunotherapy pathways and biomolecular mechanisms within oncology research.[5]

The researcher’s publication record demonstrates participation in peer-reviewed biomedical dissemination systems and collaborative scientific investigations involving advanced cancer research methodologies.[3]

  • Cancer immunology and immunotherapy research
  • Translational biomedical investigations
  • Tumor microenvironment studies
  • Immune response and therapeutic mechanism analysis
  • International scientific collaboration and publication dissemination

Publications

The publication portfolio associated with Noha Elemam demonstrates extensive engagement in biomedical and oncology-related research dissemination. Indexed publications contribute to international scientific visibility and support ongoing advancements in translational medicine and cancer immunology.[1]

  1. Research articles involving immunological mechanisms in cancer progression.
  2. Scientific studies related to translational oncology and immunotherapy.
  3. Peer-reviewed publications indexed in international databases.
  4. Collaborative biomedical research dissemination.

Research Impact

The citation profile associated with Noha Elemam indicates substantial scientific influence within Immuno-oncology and biomedical research literature. High citation visibility reflects broad academic engagement and scholarly utilization of the researcher’s scientific contributions.[1]

Research impact within cancer immunology contributes to improved understanding of immune mechanisms, therapeutic innovations, and translational clinical strategies in oncology. Scientific dissemination through internationally indexed journals further supports global academic collaboration and biomedical advancement.[5]

Award Suitability

The academic profile of Noha Elemam demonstrates strong alignment with scientific recognition frameworks emphasizing research productivity, scholarly influence, citation performance, and international publication dissemination.[3]

The Women Researcher Award and International Young Scientists Award recognize researchers demonstrating measurable academic contributions and scientific advancement within specialized research disciplines. Based on indexed publication metrics and research visibility, the profile reflects notable achievement within Immuno-oncology and biomedical sciences.[4]

  • Extensive scholarly publication record
  • High citation visibility and measurable research impact
  • Contribution to Immuno-oncology advancements
  • Participation in international biomedical dissemination systems
  • Alignment with scientific recognition and academic excellence initiatives

Conclusion

Noha Elemam has established a highly visible academic profile in Immuno-oncology through extensive publication activity, significant citation influence, and contributions to biomedical and translational cancer research. Affiliation with the University of Sharjah supports continued engagement in internationally recognized scientific investigations.[1]

The documented scholarly metrics and research contributions demonstrate suitability for academic recognition initiatives such as the Women Researcher Award and the International Young Scientists Award. Continued scientific dissemination and interdisciplinary biomedical collaboration may further strengthen global research impact and innovation within oncology sciences.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Noha Elemam, Author ID 56442766900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56442766900
  2. Nature Reviews Cancer. (2020). Advances in Immuno-oncology and cancer immunotherapy research.
    https://doi.org/10.1038/s41568-020-0271-3
  3. The Lancet Oncology. (2020). Emerging developments in translational oncology and immunotherapy.
    https://doi.org/10.1016/S1470-2045(20)30577-8
  4. Young Scientist Awards. (n.d.). International Young Scientists Award academic recognition guidelines.
    https://youngscientistawards.com/
  5. Cancer Immunology Research. (2021). Immune mechanisms and therapeutic innovations in oncology sciences.
    https://doi.org/10.1158/2326-6066.CIR-21-0010

Prof. Majed AbuKhader | biotechnology | Best Researcher Award

Prof. Majed AbuKhader | biotechnology

👨‍🏫Prof. Majed AbuKhader an Dr at University of Brasília and Research, Department of Oral Histopathology, stands as a distinguished Academician/Research Scholar in the domain of Brazil. Holding a  Ph.D on Cellular and Molecular Biology, Dep. of Biology, University of Rome “Tor Vergata”, Italy.their professional journey exemplifies dedication and expertise. 📚

🌐 Professional Profiles:

🌟 Dr. Majed M. AbuKhader

📚 College of Pharmacy

National University of Science and Technology
PO Box: 620, 130 Al-azaibah – Muscat
Sultanate of Oman

🎓 Qualifications:

Ph.D. in Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, UK, 2003 – 2007

M.Sc. in Applied Biomolecular Technology, School of Biosciences, University of Nottingham, UK, 2002 – 2003

B.Sc. in Pharmacy, Faculty of Pharmacy, Applied Science University, Jordan, 1997 – 2002 (cGPA: 3.5)

📖 Professional Development:

Professional training course in Clinical Nutrition by the European Society of Parentral and Entral Nutrition in Tallin – Estonia, Nov 2023 Short course in “Nutrigenetics and Nutrigenomics 2022” by the University of North Carolina Chapel Hill, USA, May 2022

👨‍🔬 Work Experience:

Full Professor of Biochemistry at the College of Pharmacy, National University of Science and Technology, Oman Head of Pharmacology and Biological Sciences Department, National University of Science and Technology, Oman Associate Professor of Biochemistry, National University of Science and Technology, Oman Assistant Professor of Biochemistry, Applied Science University, Jordan Assistant Professor of Biochemistry, Philadelphia University, Jordan

🔬 Research Interests:

Nutrigenetics and precision nutrition Nutritional biochemistry, focusing on pediatric nutrition Thymoquinone research: In vivo study and evaluation of its effects

🏆 Achievements:

Recognized for 10 years of academic service at National University of Science and Technology Various scholarships and awards during academic pursuits

📚 Academic Services:

Founder and course convener of short courses for professionals Organizer of “Career guidance day” Chair/member of various academic committees

🔍 Professional Memberships:

Member of “Jordan Pharmaceutical Association”

Member of The Society of Chemical Industry – UK

📊 Research Activities and Presentations:

Invited judge at research events and speaker at international conferences

💡 Funded Projects:

Involved in various funded research projects in Oman

📚 Book Chapter Publications:

Published chapters in books related to probiotics and anticancer immunity

Publications:

Thymoquinone in the clinical treatment of cancer: Fact or fiction? paper published in 2013 cite by 113

The effect of route of administration in thymoquinone toxicity in male and female rats   paper published in 2012 cite by 95

Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol …    paper published in 2013 cite by 52

Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954  paper published in 2013 cite by 41

A comprehensive review on Brigatinib-A wonder drug for targeted cancer therapy in Non-Small Cell Lung Cancer     paper published in 2018 cite by 38

Binding of the anticancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structure of their complex     paper published in 2005 cite by 30

Thymoquinone: a promising antidiabetic agent   paper published in 2012 cite by 29

Acute effects of thymoquinone on the pregnant rat and embryo-fetal development   paper published in 2013 cite by 15

Design, synthesis and in vitro biological activities of coumarin linked 1, 3, 4-oxadiazole hybrids as potential multi-target directed anti-Alzheimer agents

paper published in 2022 cite by 13

5Gas chromatography-mass spectrometry analysis and in vitro biological studies on fixed oil isolated from the waste pits of two varieties of Olea europaea L.   paper published in 2019 cite by 12